Ascorbic acid intake and oxalate synthesis
In humans, approximately 60 mg of ascorbic acid (AA) breaks down in the body each day and has to be replaced by a dietary intake of 70 mg in women and 90 mg in men to maintain optimal health and AA homeostasis. The breakdown of AA is non-enzymatic and results in oxalate formation. The exact amount of oxalate formed has been difficult to ascertain primarily due to the limited availability of healthy human tissue for such research and the difficulty in measuring AA and its breakdown products. The breakdown of 60 mg of AA to oxalate could potentially result in the formation of up to 30 mg oxalate per day. This exceeds our estimates of the endogenous production of 10–25 mg oxalate per day, indicating that degradative pathways that do not form oxalate exist. In this review, we examine what is known about the pathways of AA metabolism and how oxalate forms. We further identify how gaps in our knowledge may be filled to more precisely determine the contribution of AA breakdown to oxalate production in humans. The use of stable isotopes of AA to directly assess the conversion of vitamin to oxalate should help fill this void.
KeywordsAscorbate Vitamin C Oxalate Metabolism
Funded in part by NIH Grant DK73732.
Compliance with ethical standards
This work was supported in part by NIH grant and DK73732.
Conflict of interest
Authors declare no conflict of interest.
This article does not contain any studies with human participants or animals performed by the investigators.
- 29.Kallner A, Hartmann D, Hornig D (1977) On the absorption of ascorbic acid in man. Int J Vitam Nutr Res. Int Z fur Vitam und Ernahrungsforschung. J Int de Vitaminol et de Nutr 47:383–388Google Scholar
- 30.Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazerev A, Graumlich JF, King J, Cantilena LR (1996) Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci 93:3704–3709CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Yun J, Mullarky E, Lu C, Bosch KN, Kavalier A, Rivera K, Roper J, Chio II, Giannopoulou EG, Rago C, Muley A, Asara JM, Paik J, Elemento O, Chen Z, Pappin DJ, Dow LE, Papadopoulos N, Gross SS, Cantley LC (2015) Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science 350:1391–1396CrossRefPubMedGoogle Scholar
- 59.Holmes RP, Goodman HO, Assimos DG (1995) Dietary oxalate and its intestinal absorption. Scan Microsc 9:1109–1120Google Scholar
- 66.McHugh GJ, Graber ML, Freebairn RC (2008) Fatal vitamin C-associated acute renal failure. Anaesth Intensive Care 36:585–588Google Scholar
- 67.Gurm H, Sheta MA, Nivera N, Tunkel A (2012) Vitamin C-induced oxalate nephropathy: a case report. J Community Hosp Intern Med Perspect 2:17718Google Scholar